These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9323802)
1. Adenovirus mediated alpha interferon (IFN-alpha) gene transfer into CD34+ cells and CML mononuclear cells. Feldman E; Ahmed T; Lutton JD; Farley T; Tani K; Freund M; Asano S; Abraham NG Stem Cells; 1997; 15(5):386-95. PubMed ID: 9323802 [TBL] [Abstract][Full Text] [Related]
2. Gene transfer of alpha interferon into hematopoietic stem cells. Ahmed T; Lutton JD; Feldman E; Tani K; Asano S; Abraham NG Leuk Res; 1998 Feb; 22(2):119-24. PubMed ID: 9593468 [TBL] [Abstract][Full Text] [Related]
3. Adenovirus and retrovirus mediated interferon alpha gene transfer into CD34+ cells maintains regeneration capacity and enhances adhesion molecules in K562 cells. Seiter K; Kancherla R; Yang L; Quan S; Farley TJ; Abraham NG; Ahmed T J Investig Med; 1999 Sep; 47(8):414-24. PubMed ID: 10510594 [TBL] [Abstract][Full Text] [Related]
4. Distinct effect of retroviral-mediated IFN-alpha gene transfer on human erythroleukemic and CD34+ cell growth and differentiation. Quan S; Feldman E; Yang L; Wagener FA; Farley TJ; Abraham NG; Ahmed T J Hematother Stem Cell Res; 1999 Oct; 8(5):491-502. PubMed ID: 10791900 [TBL] [Abstract][Full Text] [Related]
5. Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectors. Watanabe T; Kuszynski C; Ino K; Heimann DG; Shepard HM; Yasui Y; Maneval DC; Talmadge JE Blood; 1996 Jun; 87(12):5032-9. PubMed ID: 8652816 [TBL] [Abstract][Full Text] [Related]
6. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors. Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928 [TBL] [Abstract][Full Text] [Related]
7. Potent antileukemic activity of the novel agents norsegoline and dibezine. Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051 [TBL] [Abstract][Full Text] [Related]
8. [Influence of IFN-alpha and IFN-alpha combined with GM-CSF on expression of the genes related to cell apoptosis of MNCs from bone marrow in CML patients]. Tang LJ; Chen HC; Peng XH Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):570-2. PubMed ID: 12516408 [TBL] [Abstract][Full Text] [Related]
9. Retroviral vector-mediated transfer of the interferon-alpha gene in chronic myeloid leukemia cells. Salesse S; Moreau-Gaudry F; Pigeonnier-Lagarde V; Mazurier F; Chahine H; Ged C; de Verneuil H; Reiffers J; Mahon FX Cancer Gene Ther; 1998; 5(6):390-400. PubMed ID: 9917094 [TBL] [Abstract][Full Text] [Related]
10. Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemia. Wandl UB; Niederle N; Kranzhoff M; Seeber S Int J Cell Cloning; 1992 Sep; 10(5):292-8. PubMed ID: 1453016 [TBL] [Abstract][Full Text] [Related]
11. Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells. de Wynter EA; Durig J; Cross MA; Heyworth CM; Testa NG Stem Cells; 1998; 16(5):349-56. PubMed ID: 9766815 [TBL] [Abstract][Full Text] [Related]
12. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients. Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929 [TBL] [Abstract][Full Text] [Related]
13. The 30/35 kDa chymotryptic fragment of fibronectin enhances retroviral-mediated gene transfer in purified chronic myelogenous leukemia bone marrow progenitors. Traycoff CM; Srour EF; Dutt P; Fan Y; Cornetta K Leukemia; 1997 Jan; 11(1):159-67. PubMed ID: 9001433 [TBL] [Abstract][Full Text] [Related]
14. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V; Ferguson KF; Heller G; Kernan NA Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927 [TBL] [Abstract][Full Text] [Related]
15. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia. Selleri C; Sato T; Del Vecchio L; Luciano L; Barrett AJ; Rotoli B; Young NS; Maciejewski JP Blood; 1997 Feb; 89(3):957-64. PubMed ID: 9028327 [TBL] [Abstract][Full Text] [Related]
16. Immunological effects of interferon-alpha on chronic myelogenous leukemia. de Castro FA; Palma PV; Morais FR; Simões BP; Carvalho PV; Ismael SJ; Lima CP; Voltarelli JC Leuk Lymphoma; 2003 Dec; 44(12):2061-7. PubMed ID: 14959848 [TBL] [Abstract][Full Text] [Related]
18. A differential sensitivity to recombinant human interferon-alpha 2a between normal and chronic myeloid leukaemic peripheral blood granulocyte-macrophage colony-forming units. Gronthos S; To LB; Haylock DN; Juttner CA Leuk Res; 1992; 16(2):153-8. PubMed ID: 1545568 [TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo. Paquette RL; Hsu N; Said J; Mohammed M; Rao NP; Shih G; Schiller G; Sawyers C; Glaspy JA Leukemia; 2002 Aug; 16(8):1484-9. PubMed ID: 12145689 [TBL] [Abstract][Full Text] [Related]
20. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells. Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]